LH vs CRL — Key Metrics
| Metric | LH (LABCORP HOLDINGS INC) | CRL (CHARLES RIVER LABORATORIES INTERNATIONAL INC) |
|---|---|---|
| Price | 308.11 | 295.01 |
| Market Cap | 24.99 Billion | 14.08 Billion |
| P/E (TTM) | 25.32 | -61.59 |
| P/B (Quarterly) | 2.958 | 4.383 |
| P/S (TTM) | 1.74 | 3.52 |
| Net Profit Margin (TTM) | 7.0 | -6.0 |
| Gross Margin (TTM) | 28.9 | 32.7 |
| ROE (TTM) | 11.6 | -7.7 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
LH · LABCORP HOLDINGS INC
Underperform
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL INC
Greatly Underperform
Recommendation Summary
Stock LH is projected to underperform the market, stock CRL is projected to greatly underperform the market. Upfront Recommendation: LH.
Financial Metrics
Prices delayed ~15 min
| LH | Metrics | CRL |
|---|---|---|
| $308.11 | Price | $295.01 |
| — | Market Capitalization | — |
| 1.74 | Price to Sales | 3.52 |
| 21.63 | Price to FCF Ratio | 38.0 |
| 6.03 | Price to Gross Profit | 10.78 |
| 6.55 | Price to Current Assets | 9.21 |